Latest Security News

Harvest Technology Group has raised $500,000 through unsecured convertible notes with a 15% annual interest rate, supporting its strategic three-year profit plan. The notes include attached options exercisable over two years, pending shareholder approval.

Biome Australia has reported record-breaking sales revenue for FY25, driven by strong domestic demand and promising international expansion. The company is on track to deliver its first full-year net profit and meet ambitious growth targets.

Copper Search Limited has secured two key exploration licences in South Australia's Eromanga Basin for Heavy Mineral Sands, setting the stage for a fully funded drilling campaign later this year. The company is also progressing copper-gold projects in New South Wales with government co-funding applications underway.

Jindalee Lithium has appointed Ian Rodger as Managing Director, marking a leadership milestone as the company advances its McDermitt Lithium Project. Rodger’s promotion follows his pivotal role in delivering key project studies and securing regulatory milestones.

BlackRock Investment Management (Australia) Limited has announced the final cash distribution amounts for over 50 Australian-listed iShares ETFs, detailing key dates and investor options for reinvestment or cash payments.

Norwood Systems has extended the repayment date on its key loan facility to July 31, 2025, with the principal reduced to $318,341 following significant repayments. This move supports the company’s ongoing growth initiatives, including its recent Optus contract win.

Green Critical Minerals has released a robust Pre-Feasibility Study for the McIntosh Graphite Project, highlighting significant economic potential and a long mine life. Meanwhile, NH3 Clean Energy advances its flagship WAH2 ammonia project towards key development milestones.

Santana Minerals has unveiled an updated Pre-Feasibility Study for its Bendigo-Ophir Gold Project, revealing lower capital costs, higher gold grades, and robust financial returns that position the project as a low-cost, high-margin operation in New Zealand.

Paradigm Biopharmaceuticals has locked in a $27 million USD convertible note facility to fully fund its pivotal Phase 3 trial for knee osteoarthritis, ensuring operational momentum through key clinical milestones.

BlackRock Investment Management (Australia) Limited has announced the final confirmed cash distributions for nine Australian domiciled iShares ETFs, outlining key dates and investor requirements.

Proteomics International, alongside key partners, is investing $6 million to expand the WA Proteomics Facility, aiming to establish a nationally accredited platform for industrial-scale protein biomarker analysis in medicine and agriculture.

Sprintex Limited has extended convertible note and loan agreements totaling A$2.85 million, bolstering financial flexibility as it prepares for a significant sales trial with the Van Drie Group that could unlock over A$8.5 million in revenue.